Drugmaker Mallinckrodt in talks with hedge funds for potential bankruptcy to avoid opioid settlements
Mallinckrodt aims to write off $1 billion in debts owed to addiction victims and government entities
Fox News Flash top headlines for July 27
Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com.
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids, the Wall Street Journal reported on Wednesday.
Shares of the company rose 53.3% to 69 cents in afternoon trade.
As part of a prearranged deal, Mallinckrodt will propose to write off about $1 billion from what it still owes to addiction victims and state and local governments, while making a one-time payment of roughly $250 million, the report said, citing people familiar with the discussions.
Mallinckrodt did not immediately respond to a Reuters request for comment.
Bottles of prescription painkiller Oxycodone Hydrochloride, 30mg pills, made by Mallinckrodt sit on a shelf at a local pharmacy, in Provo, Utah, on April 25, 2017. (REUTERS/George Frey/File Photo)
CLICK HERE TO GET THE FOX NEWS APP
A group of hedge funds, including Greenwich and Silver Point Capital, is in negotiations with Mallinckrodt's board to give them control of the business through a bankruptcy filing, according to people familiar with the discussions, the report said.
Mallinckrodt, which is one of the largest manufacturers for opiods, had filed for bankruptcy protection nearly three years ago. It reached a $1.7 billion nationwide settlement as part of its bankruptcy reorganization plan and emerged from Chapter 11 last year.
The company in June said it was considering a second bankruptcy filing and other options after its lenders raised concerns over the $200 million payment related to opioid-related litigation.
Get all the stories you need-to-know from the most powerful name in news delivered first thing every morning to your inbox
